BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28474964)

  • 1. Aggressive Salivary Malignancies at Early Stage: Outcomes and Implications for Treatment.
    Eppsteiner RW; Fowlkes JW; Anderson CM; Robinson RA; Pagedar NA
    Ann Otol Rhinol Laryngol; 2017 Jul; 126(7):525-529. PubMed ID: 28474964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma ex pleomorphic adenoma: a clinicopathologic review.
    Olsen KD; Lewis JE
    Head Neck; 2001 Sep; 23(9):705-12. PubMed ID: 11505478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of nasopharyngeal salivary gland malignancy.
    Schramm VL; Imola MJ
    Laryngoscope; 2001 Sep; 111(9):1533-44. PubMed ID: 11568602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of minor salivary gland carcinomas.
    Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):443-54. PubMed ID: 8655366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant epithelial salivary gland tumors. Clinical review of 2 decades].
    Kokemüller H; Brüggemann N; Brachvogel P; Eckardt A
    Mund Kiefer Gesichtschir; 2004 May; 8(3):191-201. PubMed ID: 15138857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative irradiation of minor salivary gland malignancies of the head and neck.
    Le QT; Birdwell S; Terris DJ; Gabalski EC; Varghese A; Fee We; Goffinet DR
    Radiother Oncol; 1999 Aug; 52(2):165-71. PubMed ID: 10577702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoepidermoid Carcinoma: A 23-Year Experience with Emphasis on Low-Grade Tumors with Close/Positive Margins.
    Spellman J; Calzada G
    Otolaryngol Head Neck Surg; 2018 May; 158(5):889-895. PubMed ID: 29313462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoepidermoid carcinoma arising from pleomorphic adenoma of the soft palate.
    Benazzou S; Boulaadas M; Sefiani S; El Kohen A; Essakalli L; Kzadri M
    J Craniofac Surg; 2006 Nov; 17(6):1192-4. PubMed ID: 17119430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.
    Chen AM; Garcia J; Bucci MK; Quivey JM; Eisele DW
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):138-43. PubMed ID: 17049183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neck masses secondary to heterotopic salivary gland tissue: a 25-year experience.
    Daniel E; McGuirt WF
    Am J Otolaryngol; 2005; 26(2):96-100. PubMed ID: 15742261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors affecting the clinical outcome of carcinoma ex pleomorphic adenoma in the major salivary gland.
    Zhao J; Wang J; Yu C; Guo L; Wang K; Liang Z; Lou J
    World J Surg Oncol; 2013 Aug; 11(1):180. PubMed ID: 23924064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of patients with malignant salivary gland tumors.
    Bell RB; Dierks EJ; Homer L; Potter BE
    J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome.
    Xu B; Aneja A; Ghossein R; Katabi N
    Hum Pathol; 2017 Sep; 67():37-44. PubMed ID: 28739497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease.
    Erovic BM; Schopper C; Pammer J; Vormittag L; Maleki A; Brunner M; Heiduschka G; Grasl MCh; Thurnher D
    Head Neck; 2010 Sep; 32(9):1167-72. PubMed ID: 20191625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masses of the salivary gland region in children.
    Bentz BG; Hughes CA; Lüdemann JP; Maddalozzo J
    Arch Otolaryngol Head Neck Surg; 2000 Dec; 126(12):1435-9. PubMed ID: 11115277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience.
    Aro K; Leivo I; Mäkitie AA
    Laryngoscope; 2008 Feb; 118(2):258-62. PubMed ID: 18030166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of MUC1 predicts poor survival in salivary gland mucoepidermoid carcinoma.
    Liu S; Ruan M; Li S; Wang L; Yang W
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1891-6. PubMed ID: 25187376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.